Atomwise Stock
Atomwise develops artificial intelligence systems using powerful deep learning algorithms and supercomputers for drug discovery.
Sign up today and learn more about Atomwise Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Atomwise Stock
The Atomwise Advantage Using computers to discover medicines is a great idea, but execution is everything. With lives and budgets on the line, accuracy matters. Previous attempts haven't always met expectations. The techniques of the day were limited by the knowledge and computers available. Today, things are different. They have invented cutting-edge machine learning algorithms that are built specifically for the world's most powerful computers. They use one of the world's top supercomputers to analyze databases 1000 times larger than those used in the past. This lets us deliver what many others can't: precise and reliable medicinal predictions.
Funding History
January 2013 | $225K |
---|---|
December 2014 | $120K |
March 2015 | $225K |
June 2015 | $6.0M |
Management
CEO
Abraham Heifets
CTO
Dr. Izhar Wallach
COO
Alexander Levy
Press
finance - Jan, 26 2024
Artificial Intelligence in Drug Discovery Market is Expected to ...biospace - Jan, 26 2024
Launch of Insilico’s Phase II Program Highlights Generative AI ...labiotech - Jan, 26 2024
How French pharma giant Sanofi is betting big on AIbioworld - Oct, 5 2023
Atomwise nominates TYK2 inhibitor development candidate